This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Cellectar Biosciences, Inc., Wisconsin Alumni Research Foundation. Active years: 2016-2022.
Company Filing History:
4 out of 10 
1 out of 4,226 
Years Active: 2016-2022
Title: The Innovative Contributions of Benjamin Titz
Introduction
Benjamin Titz is a notable inventor based in Madison, WI (US), recognized for his significant contributions to the field of cancer treatment. With a total of 5 patents, Titz has dedicated his career to developing therapeutic compounds that target cancer cells and cancer stem cells.
Latest Patents
One of Titz's latest patents is focused on phospholipid ether analogs as cancer-targeting drug vehicles. This invention is directed to therapeutic compounds capable of specifically targeting cancer cells and cancer stem cells. The patent also encompasses compositions that include these therapeutic compounds and outlines methods for treating cancer through their administration.
Career Highlights
Throughout his career, Benjamin Titz has worked with prominent organizations such as Cellectar Biosciences, Inc. and the Wisconsin Alumni Research Foundation. His work in these institutions has allowed him to advance his research and contribute to innovative solutions in cancer therapy.
Collaborations
Titz has collaborated with several professionals in his field, including Jamey Paul Weichert and Chorom Pak. These collaborations have further enriched his research and development efforts.
Conclusion
Benjamin Titz's innovative work in cancer-targeting drug vehicles exemplifies his commitment to advancing medical science. His contributions are paving the way for more effective cancer treatments, showcasing the importance of innovation in healthcare.